According to the recently published Vaccine Partnering Terms & Agreements report, throughout the past 5 years there has been a significant increase in vaccine partnering and collaboration.
Looking at a figure showing partnering deals from 2007 to 2012, we see a rise in frequency from 2007 with a peak in 2010. Since then, however, there has been a decline in the number of vaccine partnerships and M&A activity.
For the full report, click here
This article is abstracted from the recently published Vaccine Partnering Terms & Agreements report.
As for vaccine deals by therapy area, from 2007 to 2012, the leading sectors include infectives and oncology. See below.
Figure 2: Vaccine deals by therapy area – 2007 to 2012
For more on trends in partnering and collaboration, click here